Loading company
MDTMedtronic plc$131.6BA+Built from Neuroone Medical Technologies Corp’s own filings with the U.S. Securities and Exchange Commission (SEC). Figures are as reported, with per-share history restated onto today’s share basis. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.
The themes Neuroone Medical Technologies is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
$0.76-2.6%Nov 11 close
Reported results on October 5, 2026; they are not in these figures yet.
Next earnings: December 15, 2026
Figures through June 30, 2026, from the 10-Q filed August 13, 2026
Company outlook: revenue of about $10.5M for Fiscal year 2026 — up 15.4% on a year earlier
Grade D-
The band under the price shows the grade on each date, built only from filings that were public by then.
Showing 2 of 27 quarters of Neuroone Medical Technologies Corp’s grade history. The other 25 go back to November 2016.
